Summary
Latest filing:
Rekha Hemrajani files SEC Form 4 reports at MAXCYTE, INC. (MXCT). 8 SEC Form 4 filings on record going back to 2024, most recently on 22 June 2026. Most recent open-market trade: sold $22K of MXCT on 25 June 2025. Lifetime open-market purchases: $46K. Lifetime open-market sales: $22K.
Recent transactions
4The latest 4 SEC Form 4 transactions reported by Rekha Hemrajani.
Trading pattern
InsiderAlpha's records for Rekha Hemrajani go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. The typical open-market purchase is $46K (1 buy totaling $46K). The largest single buy on record is $46K of ALXO in 2024. Sales side: 1 recorded sale totaling $22K, so the filing history runs buy-heavy by dollar value. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Rekha Hemrajani files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Deep Track Biotechnology Master Fund, Ltd. - $20.00M in LBRX purchases and sales in the last 12 months
- Kristen Fortney - $4.22M in BIOA purchases and sales in the last 12 months
- Shane Barton - $1.58M in BIOA purchases and sales in the last 12 months
- Paul D. Rubin - $1.15M in BIOA purchases and sales in the last 12 months
- Dov A. Md Goldstein - $532K in BIOA purchases and sales in the last 12 months
- Douglas J. Swirsky - $8K in MXCT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Rekha Hemrajani?
Rekha Hemrajani is a corporate insider of MAXCYTE, INC. (MXCT). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Rekha Hemrajani last file a Form 4?
The most recent primary Form 4 on record is dated 22 June 2026, one of 8 filings going back to 2024.
Has Rekha Hemrajani been buying or selling stock?
Recorded transactions: 1 open-market purchase ($46K) and 1 open-market sale ($22K) across all tracked filings.